The estimated Net Worth of Peter J Arduini is at least $22.4 million dollars as of 2 September 2021. Mr. Arduini owns over 118,434 units of Integra Lifesciences Corp stock worth over $4,634,397 and over the last 20 years he sold IART stock worth over $9,906,594. In addition, he makes $7,859,420 as President, Chief Executive Officer et Director at Integra Lifesciences Corp.
Peter has made over 30 trades of the Integra Lifesciences Corp stock since 2008, according to the Form 4 filled with the SEC. Most recently he exercised 118,434 units of IART stock worth $2,472,902 on 2 September 2021.
The largest trade he's ever made was exercising 250,000 units of Integra Lifesciences Corp stock on 6 September 2019 worth over $3,472,500. On average, Peter trades about 7,436 units every 47 days since 2005. As of 2 September 2021 he still owns at least 263,318 units of Integra Lifesciences Corp stock.
You can see the complete history of Mr. Arduini stock trades at the bottom of the page.
Peter J. Arduini serves as President, Chief Executive Officer, Director of the Company. He joined Integra in November 2010 as President and Chief Operating Officer and was appointed Chief Executive Officer and a director in January 2012. Before joining Integra, Mr. Arduini was corporate vice president and president of Medication Delivery, Baxter Healthcare, from 2005 to 2010. Mr. Arduini was responsible for a $4.8 billion global division of Baxter focused on inpatient pharmaceuticals and devices. Prior to that, he worked for 15 years in a variety of management roles for domestic and global business for General Electric Healthcare, culminating in leading the global functional imaging business. Mr. Arduini currently serves on the board of directors of Bristol-Myers Squibb Company, where he is a member of the audit committee and the compensation and management development committee. He serves on the board of directors of ADVAMED, the Advanced Medical Technology Association, the Medical Device Innovation Consortium, and the National Italian American Foundation. He also serves on the board of trustees of Susquehanna University. Mr. Arduini received his bachelor’s degree in marketing from Susquehanna University and a master’s in management from Northwestern University’s Kellogg School of Management.
As the President, Chief Executive Officer et Director of Integra Lifesciences Corp, the total compensation of Peter Arduini at Integra Lifesciences Corp is $7,859,420. There are no executives at Integra Lifesciences Corp getting paid more.
Peter Arduini is 55, he's been the President, Chief Executive Officer et Director of Integra Lifesciences Corp since 2012. There are 11 older and 10 younger executives at Integra Lifesciences Corp. The oldest executive at Integra Lifesciences Holdings Corp is Dr. Richard E. Caruso, 78, who is the Founder and Chairman Emeritus.
Peter's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543.
Over the last 22 years, insiders at Integra Lifesciences Corp have traded over $397,927,161 worth of Integra Lifesciences Corp stock and bought 132,879 units worth $4,504,827 . The most active insiders traders include Neal Moszkowski, Stuart Essig et George Soros. On average, Integra Lifesciences Corp executives and independent directors trade stock every 19 days with the average trade being worth of $668,131. The most recent stock trade was executed by Jeffrey Mosebrook on 19 August 2024, trading 1,191 units of IART stock currently worth $25,702.
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li
Integra Lifesciences Corp executives and other stock owners filed with the SEC include: